307 related articles for article (PubMed ID: 18422497)
1. Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadism.
Yasuda M; Ide H; Furuya K; Yoshii T; Nishio K; Saito K; Isotani S; Kamiyama Y; Muto S; Horie S
J Sex Med; 2008 Jun; 5(6):1482-91. PubMed ID: 18422497
[TBL] [Abstract][Full Text] [Related]
2. Endothelial antioxidant administration ameliorates the erectile response to PDE5 regardless of the extension of the atherosclerotic process.
Vicari E; La Vignera S; Condorelli R; Calogero AE
J Sex Med; 2010 Mar; 7(3):1247-53. PubMed ID: 19674252
[TBL] [Abstract][Full Text] [Related]
3. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a couple study.
Chevret-Méasson M; Lavallée E; Troy S; Arnould B; Oudin S; Cuzin B
J Sex Med; 2009 Mar; 6(3):761-9. PubMed ID: 19143916
[TBL] [Abstract][Full Text] [Related]
4. Men with mild erectile dysfunction benefit from sildenafil treatment.
Bénard F; Carrier S; Lee JC; Talwar V; Defoy I
J Sex Med; 2010 Nov; 7(11):3725-35. PubMed ID: 20946161
[TBL] [Abstract][Full Text] [Related]
5. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial.
Moncada I; Martínez-Jabaloyas JM; Rodriguez-Vela L; Gutiérrez PR; Giuliano F; Koskimaki J; Farmer IS; Renedo VP; Schnetzler G
J Sex Med; 2009 Dec; 6(12):3469-77. PubMed ID: 19796051
[TBL] [Abstract][Full Text] [Related]
6. Negative impact of metabolic syndrome on the responsiveness to sildenafil in Japanese men.
Suetomi T; Kawai K; Hinotsu S; Joraku A; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
J Sex Med; 2008 Jun; 5(6):1443-50. PubMed ID: 18208503
[TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy in erectile dysfunction and hypogonadism.
Shabsigh R
J Sex Med; 2005 Nov; 2(6):785-92. PubMed ID: 16422803
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction.
Park K; Ku JH; Kim SW; Paick JS
BJU Int; 2005 Feb; 95(3):366-70. PubMed ID: 15679795
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, double-blind, placebo-controlled trial to assess the efficacy of sildenafil citrate in men with unrecognized erectile dysfunction.
Shabsigh R; Kaufman J; Magee M; Creanga D; Russell D; Budhwani M
Urology; 2010 Aug; 76(2):373-9. PubMed ID: 20579708
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
11. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.
Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H
J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755
[TBL] [Abstract][Full Text] [Related]
12. Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase.
Kadioglu A; Grohmann W; Depko A; Levinson IP; Sun F; Collins S
J Sex Med; 2008 Mar; 5(3):726-34. PubMed ID: 18086165
[TBL] [Abstract][Full Text] [Related]
13. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
Hwang TI; Chen HE; Tsai TF; Lin YC
Int J Impot Res; 2006; 18(4):400-4. PubMed ID: 16395321
[TBL] [Abstract][Full Text] [Related]
14. Couple satisfaction to different therapeutic modalities for organic erectile dysfunction.
Hassan A; El-Hadidy M; El-Deeck BS; Mostafa T
J Sex Med; 2008 Oct; 5(10):2381-91. PubMed ID: 18179457
[TBL] [Abstract][Full Text] [Related]
15. Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: a pilot study.
Shamloul R; Ghanem H; Fahmy I; El-Meleigy A; Ashoor S; Elnashaar A; Kamel I
J Sex Med; 2005 Jul; 2(4):559-64. PubMed ID: 16422854
[TBL] [Abstract][Full Text] [Related]
16. An open-label, multicenter, flexible dose study to evaluate the efficacy and safety of Viagra (sildenafil citrate) in Korean men with erectile dysfunction and arterial hypertension who are taking antihypertensive agents.
Park HJ; Park NC; Shim HB; Park JK; Lee SW; Park K; Kim SW; Moon KH; Lee DH; Yoon SJ
J Sex Med; 2008 Oct; 5(10):2405-13. PubMed ID: 18466269
[TBL] [Abstract][Full Text] [Related]
17. Scoring correspondence in outcomes related to erectile dysfunction treatment on a 4-point scale (SCORE-4).
Cappelleri JC; Bushmakin AG; Symonds T; Schnetzler G
J Sex Med; 2009 Mar; 6(3):809-19. PubMed ID: 19143915
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil.
Dadkhah F; Safarinejad MR; Asgari MA; Hosseini SY; Lashay A; Amini E
Int J Impot Res; 2010; 22(1):51-60. PubMed ID: 19865092
[TBL] [Abstract][Full Text] [Related]
19. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
McVary KT; Kaufman J; Young JM; Tseng LJ
Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
